EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside

Fei Xie, Yifei Song, Yang Yi, Xue Jiang, Shiwen Ma, Chen Ma, Junyu Li, Ziyi Zhanghuang, Mengyu Liu, Pengxiang Zhao, Xuemei Ma

Pharmaceuticals · 04.04.2023 · 16 (4) · 541

DOI: 10.3390/ph16040541 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 04.04.2023. Verfasst von Fei Xie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agro-scientific Research in the Public Interest, Military Logistics Key Open Research Projects, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress and chronic inflammation have been implicated in the pathophysiology of metabolic diseases, including diabetes mellitus (DM), metabolic syndrome (MS), fatty liver (FL), atherosclerosis (AS), and obesity. Molecular hydrogen (H2) has long been considered a physiologically inert gas. In the last two decades, accumulating evidence from pre-clinical and clinical studies has indicated that H2 may act as an antioxidant to exert therapeutic and preventive effects on various disorders, including metabolic diseases. However, the mechanisms underlying the action of H2 remain unclear. The purpose of this review was to (1) provide an overview of the current research on the potential effects of H2 on metabolic diseases; (2) discuss the possible mechanisms underlying these effects, including the canonical anti-oxidative, anti-inflammatory, and anti-apoptotic effects, as well as suppression of ER stress, activation of autophagy, improvement of mitochondrial function, regulation of gut microbiota, and other possible mechanisms. The potential target molecules of H2 will also be discussed. With more high-quality clinical trials and in-depth mechanism research, it is believed that H2 will eventually be applied to clinical practice in the future, to benefit more patients with metabolic disease.

Schlagwörter

Stichwörter der Autor:innen

clinical trialsmetabolic diseasesmolecular hydrogen (H2)oxidative stresspre-clinical studies

Autor:innen und Institutionen

  • Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China.
  • Beijing Molecular Hydrogen Research Center, Beijing 100124, China.

Förderung

  • Agro-scientific Research in the Public Interest
  • Military Logistics Key Open Research Projects
  • National Natural Science Foundation of China

Zitieren

APA

Xie, F., Song, Y., Yi, Y., Jiang, X., Ma, S., Ma, C., Li, J., Zhanghuang, Z., Liu, M., Zhao, P., & Ma, X. (2023). Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside. Pharmaceuticals, 16(4), 541. https://doi.org/10.3390/ph16040541

Vancouver

Xie F, Song Y, Yi Y, Jiang X, Ma S, Ma C, et al. Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside. Pharmaceuticals. 2023;16(4):541. doi:10.3390/ph16040541

BibTeX
@article{Xie2023,
  author = {Xie, Fei and Song, Yifei and Yi, Yang and Jiang, Xue and Ma, Shiwen and Ma, Chen and Li, Junyu and Zhanghuang, Ziyi and Liu, Mengyu and Zhao, Pengxiang and Ma, Xuemei},
  title = {Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {4},
  pages = {541},
  doi = {10.3390/ph16040541}
}
Kostenlos starten →